Failed Content Uniformity Specifications: Recall is being carried out due to an out-of-specification result for content uniformity.
Failed Content Uniformity Specifications: Recall is being carried out due to an out-of-specification result for content uniformity.
We break every recall down into plain English — this one’s still on our list. Until our write-up is ready, the official FDA hazard and remedy below have the full, accurate details.
We’ve drafted a message you can send Teva Pharmaceuticals USA, Inc to request your refund or repair — edit it as you like.
Subject: Recall D-237-2013 — Teva Pharmaceuticals USA, Inc Teva Pharmaceuticals USA, Inc. recalls CLONAZEPAM ORALLY DISINTERGRATI Hello, I own a Teva Pharmaceuticals USA, Inc. recalls CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0.5 mg, 60 tablets (10 blister cards of 6 tablets each), TEVA that is covered by recall D-237-2013 from Teva Pharmaceuticals USA, Inc. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
